Morphin 100 Retard (Morphine Sulfate)

Morphine sulfate binds to mu‑opioid receptors in the central nervous system, acting as a full agonist. This interaction inhibits the release of excitatory neurotransmitters, reduces neuronal firing in pain pathways, and alters the perception of pain, resulting in analgesia and often sedation.

The appropriate dose of Morphin 100 Retard is individualized and determined by the prescribing clinician based on the patient’s pain severity, prior opioid exposure, renal and hepatic function, and overall clinical condition. Dosage adjustments are made to achieve effective pain relief while minimizing adverse effects.

Safety data for morphine sulfate in pregnancy and lactation are limited, and the drug is generally classified as contraindicated or to be used only when the potential benefit justifies the risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To order Morphin 100 Retard, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both morphine and oxycodone are strong opioid analgesics, but morphine has a longer history of use and is often available in a prolonged‑release formulation like Morphin 100 Retard. Oxycodone may have a slightly faster onset but can be associated with a higher incidence of certain gastrointestinal side effects. Choice depends on patient response, tolerability, and prescriber preference.

Morphin 100 Retard should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not store in bathrooms or other humid environments.

Morphin 100 Retard is taken orally. The tablet should be swallowed whole with a full glass of water and not chewed, crushed, or broken, as this could release the entire dose at once and increase the risk of serious side effects.

The most serious risks include respiratory depression, severe hypotension, opioid dependence or addiction, and rare but life‑threatening allergic reactions such as anaphylaxis. Patients should be monitored closely for signs of shallow breathing, excessive sedation, or any unexpected allergic symptoms.

Morphin 100 Retard is contraindicated in patients with known hypersensitivity to morphine or any component of the formulation, those with severe respiratory insufficiency, acute or severe bronchial asthma, and patients who have taken monoamine oxidase inhibitors within the past 14 days. Caution is also advised in individuals with significant renal or hepatic impairment.